AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Pershing Square Holdings Ltd Major Shareholding Notification 2015

Mar 10, 2015

6183_iss_2015-03-09_26fd61e4-0d7c-40d1-a8ac-7035de68c560.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Pershing Square Announces New Position in Valeant Pharmaceuticals International

Amsterdam, 9 Mar. 2015 //‐ Pershing Square Holdings, Ltd. (ticker: PSH:NA) announced today a new position in Valeant Pharmaceuticals International, Inc. (ticker: NYSE: VRX) representing approximately 16.9% of the PSH portfolio (based on the closing NAV of PSH and the closing share price of VRX on Friday, 6 March 2015).

Pershing Square Capital Management, L.P., the investment manager for Pershing Square Holdings, Ltd., announced that various funds it manages have purchased 16,473,933 shares of Valeant Pharmaceuticals International, Inc., representing 4.9% of Valeant.

About Pershing Square Holdings, Ltd.

Pershing Square Holdings, Ltd. is a concentrated, research‐intensive, fundamental value investor in the public markets.

MEDIA CONTACTS

StockWell Communications

Tim Burt, +44 (0)20 7240 2486

[email protected]